Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo. Alvarez, G., Martinez, J., Varela, J., Birriel, E., Cruces, E., Gabay, M., Leal, S. M., Escobar, P., Aguirre-Lopez, B., Cabrera, N., Tuena de Gomez-Puyou, M., Gomez Puyou, A., Perez-Montfort, R., Yaluff, G., Torres, S., Serna, E., Vera de Bilbao, N., Gonzalez, M., & Cerecetto, H. Eur J Med Chem, 100:246–256, Jul, 2015.
bibtex   
@Article{pmid26094151,
   Author="Alvarez, G.  and Martinez, J.  and Varela, J.  and Birriel, E.  and Cruces, E.  and Gabay, M.  and Leal, S. M.  and Escobar, P.  and Aguirre-Lopez, B.  and Cabrera, N.  and Tuena de Gomez-Puyou, M.  and Gomez Puyou, A.  and Perez-Montfort, R.  and Yaluff, G.  and Torres, S.  and Serna, E.  and Vera de Bilbao, N.  and Gonzalez, M.  and Cerecetto, H. ",
   Title="{{D}evelopment of bis-thiazoles as inhibitors of triosephosphate isomerase from {T}rypanosoma cruzi. {I}dentification of new non-mutagenic agents that are active in vivo}",
   Journal="Eur J Med Chem",
   Year="2015",
   Volume="100",
   Pages="246--256",
   Month="Jul"
}

% 26085036

Downloads: 0